Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:1:83.
doi: 10.4103/2277-9175.103005. Epub 2012 Oct 31.

Comparison of intelligence quotient in children surviving leukemia who received different prophylactic central nervous system treatments

Reisi Nahid  1 , Khalilian Leila
Affiliations

Comparison of intelligence quotient in children surviving leukemia who received different prophylactic central nervous system treatments

Reisi Nahid et al. Adv Biomed Res. 2012.

Abstract

Background: Neurocognitive deficits and decrease in intelligence quotient (IQ) is one of the complication of prophylactic central nervous system (CNS) treatment in acute lymphoblastic leukemia (ALL) patients. In this study, we compare the IQ in survivors of ALL that were treated with different prophylactic CNS treatments.

Materials and methods: We compared 43 long-term survivors of ALL: 21 survivors with intrathecal methotrexate (IT MTX) as CNS prophylaxis, 22 with IT MTX+1800-2400 rads cranial irradiation and 20 healthy controls. The IQ was measured using the Raven's test in these patients.

Results: Raven's test revealed significant differences in IQ between the survivors of ALL that were treated with IT MTX, IT MTX plus cranial irradiation and control group. There was no significant difference in the IQ with respect to sex, age and irradiation dose.

Conclusion: We can that reveal that CNS prophylaxis treatment, especially the combined treatment, is associated with IQ score decline in ALL survivors. Therefore,a baseline and an annual assessment of their educational progress are suggested.

Keywords: Acute lymphoblastic leukemia; chemotherapy; intelligence quotient; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Comparison of the intelligence quotient in three groups
Figure 2
Figure 2
Correlation between the age at diagnosis and intelligence quotient scores
See this image and copyright information in PMC

References

    1. Carey ME, Haut MW, Reminger SL, Hutter JJ, Theilmann R, Kaemingk KL, et al. Reducedfrontal white matter volume in long-term childhood leukemiasurvivors: Avoxel-based morphometrystudy. AJNR Am J Neuroradiol. 2008;29:792–97. - PMC - PubMed
    1. Williams J, Michael, Davis Kelli S. Central nervous system prophylactic treatment for childhood leukemia: neuropsychological outcome studies. Cancer Treat Rev. 1986;13:113–27. - PubMed
    1. Allen JC. The effects of cancer therapy on the nervous system. JPediatr. 1978;93:903–9. - PubMed
    1. Montour-Proulx I, Kuehn SM, Keene DL, Barrowman NJ, Hsu E, Matzinger MA, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 Protocol. J Child Neurol. 2005;20:129–33. - PubMed
    1. Saro H, Armenian, Medows Anna T., Bhatia Smita. Late effects of childhood cancer and its treatment. (Neurocongnitive Sequelae) in Pizzo. In: Philip A, Poplack David G, editors. Principles and Practice of Pediatric Oncology. 6th edition. 2011. pp. 137–4.